-
Data breach at medical giant Cencora exposes info from multiple drug companies" data-before-rewrite-localise="/pro/security/data-breach-at-medical-giant-cencora-exposes-info-from-multiple-drug-companies
27 May 2024 16:06 GMT
… down from pharma giant Cencora.
In late February 2024, drug wholesale company … Pharmaceuticals, and Dendreon Pharmaceuticals.
The companies lost customers’ full names, postal addresses, health diagnoses, medications …
-
WestGene wins FDA nod to study mRNA vaccine to treat certain cancers
10 May 2024 20:00 GMT
The US Food and Drug Administration (FDA) has approved an IND to … therapies.
In 2010, the FDA approved Dendreon Pharmaceutical’s prostate cancer prophylactic Provenge … wide range of conditions.
Some pharmaceutical companies are using the mRNA …
-
Deoxyribonucleic Acid (DNA) Vaccines Market Size to Reach $7.41 Bn by 2030: Latest Report by Vantage Market Research
27 May 2024 09:18 GMT
… ; Co.
• Mitsubishi Tanabe
• Dendreon Corporation
• ASTELLAS PHARMA
• Dynavax Technologies
• Sanofi
• … expanding focus on personalized medicine offers a unique opportunity … attributed to its advanced healthcare infrastructure, significant investment in …
-
Immuno-oncology Drugs Market to See Huge Growth by 2031:Novartis AG, Pfizer Inc., Sanofi, Ferring B.V., Enzo Biochem Inc
11 Apr 2024 10:16 GMT
… ◘ Bristol-Myers Squibb Company
◘ Dendreon Pharmaceuticals LLC.
◘ F. Hoffmann-La … ◘ BioNTech SE
◘ Blueprint Medicines Corporation
◘ Regeneron Pharmaceuticals Inc.
◘ CytomX Therapeutics … and Credibility: Immuno-oncology Drugs Market research reports offer …
-
Vertex to buy kidney disease drugmaker Alpine for $4.9B
11 Apr 2024 00:00 GMT
… highly successful cystic fibrosis medicines, which have catapulted it … the Swiss pharma said that patients treated with the drug demonstrated … , a marker of kidney health. The company this year … head of cancer biotech Dendreon. Alpine employs approximately 145 …
-
A Deep Dive into the CAR T Cell Therapy Market Size 2024-2031 Industry Overview and Forecast | Autolus Therapeutics
24 May 2024 11:54 GMT
… Therapeutics
◘ JW Therapeutics Co., Ltd.,
◘ Dendreon Pharmaceuticals LLC.
◘ Autolus Therapeutics
◘ APAC Biotech … , which was the first FDA approved CAR T cell therapy … cell therapies also require considerable healthcare resources for administration and to …
-
Biologic Therapeutic Drugs: Technologies and Global Market Report 2024, with Company Profiles of Amgen, Abbive, Eli Lilly, Novartis and Glaxosmithkline - ResearchAndMarkets.com
12 Feb 2024 15:21 GMT
… implications for the future of medicine and industry advancement. For companies … Top Biologic Drug Startups
Flourishing Biotech Startups
Chapter 12 FDA Approved Monoclonal …
Amgen
Baxter
Boehringer Ingelheim
CSL
Dendreon Pharmaceuticals
Eli Lilly.
F. Hoffmann- …
-
Global Biologic Therapeutic Drugs Market Report 2024 with Focus on Emerging Technology for Biologics Manufacturing
09 Feb 2024 01:23 GMT
… implications for the future of medicine and industry advancement. For companies … Top Biologic Drug Startups
Flourishing Biotech Startups
Chapter 12 FDA Approved Monoclonal …
Amgen
Baxter
Boehringer Ingelheim
CSL
Dendreon Pharmaceuticals
Eli Lilly.
F. Hoffmann- …
-
Cell and gene therapies – top pharmaceutical industry trend to watch for 2024
29 Jan 2024 14:01 GMT
… first autologous dendritic cell therapy, Dendreon Pharmaceuticals’s Provenge (sipuleucel-T), was … that 18% (N=21) of healthcare industry professionals believed that CGT … pharmaceutical industry in 2024. This was followed by personalized/precision medicine …
-
Autologous Cell Therapy Market Size (USD 29.1 billion by 2031) Pioneering Growth to Fulfill Healthcare Requirements
06 Dec 2023 06:43 GMT
… workflows in the healthcare sector worldwide. … life-saving medical products in … , Inc.)
• Novartis AG
• Sanpower Group (Dendreon Pharmaceuticals LLC.)
• Tegoscience
• Vericel Corporation.
𝐀𝐮𝐭𝐨𝐥𝐨𝐠𝐨𝐮𝐬 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 …